A provision that would have shielded the Sackler’s from further liability in cases related to the opioid crisis fueled the 5-4 decision that sent both sides back to the negotiating table. This time, ...
If approved, the settlement will end the Sackler’s control of Purdue Pharma and prevent them from selling opioids in the U.S. Funding will directly support opioid addiction treatment ...
If approved, the settlement will end the Sackler’s control of Purdue Pharma and prevent them from selling opioids in the U.S. Funding will directly support opioid addiction treatment, prevention and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback